Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Embecta's annualizedGross Profit for the quarter that ended in Dec. 2024 was $628 Mil.
Embecta's average Total Assets over the quarter that ended in Dec. 2024 was $1,217 Mil. Therefore, Embecta's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 51.62%.
Embecta Gross-Profit-to-Asset % Historical Data
The historical data trend for Embecta's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Embecta's Gross-Profit-to-Asset %
For the Medical Instruments & Supplies subindustry, Embecta's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embecta's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embecta's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Embecta's Gross-Profit-to-Asset % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Dec. 2024) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Embecta Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Embecta's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EMBC has been successfully added to your 